HSP90B1 and cancer: In cancer cells, surface GRP94 imparts an aggressive phenotype by regulating the stability of receptor tyrosine kinases (RTKs), such as HER2 and EGFR, inhibiting their internalization and enhancing their aberrant downstream signaling [132,133,134,135].